Clinical Trial

ObvioHealth Announces the Appointment of Nicholas Campbell to Its Board of Directors

Seasoned Healthcare Executive Nicholas Campbell Joins ObvioHealth Board of Directorsto Drive Digital Innovation in Clinical Trials NEW YORK, Oct. 10,…

3 months ago

Microsoft expands AI capabilities to shape a healthier future

REDMOND, Wash., Oct. 10, 2024 /PRNewswire/ -- On Thursday, Microsoft Corp. is unveiling several Microsoft Cloud for Healthcare innovations that…

3 months ago

Dynocardia’s Direct Continuous Blood Pressure Monitoring Technology Receives Grant from NIH’s Commercialization Readiness Pilot Program

The grant, which is awarded to companies developing significantly impactful technologies with the potential to change clinical practice, will support…

3 months ago

Movano Health Provides Update on FDA Review of EvieMED Ring

The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Oct.…

3 months ago

Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders Strategic Partnership: Streamlined, single-vendor…

3 months ago

International Myeloma Foundation Launches Clinical Trial Matching Engine in Partnership with SparkCures

SparkCures’ best-in-class clinical trial matching and navigation service is now accessible via myeloma.org.STUDIO CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE)…

3 months ago

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the…

3 months ago

Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics

DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company…

3 months ago

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

Company’s VP of Education and Global Training Named Chairman of ASRM Corporate Member CouncilATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) --…

3 months ago

Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)

– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical…

3 months ago